AbCellera

Graphic image of an arrow nailing the bullseye of a target

AbCellera tops ‘most aggressive’ hopes, putting rivals on notice

AbCellera saw phase 2 results “beyond even the most aggressive upside scenario” that its CEO had considered, sending shares up 30% in pre-market trading.

Nick Paul Taylor Aug 10, 2026 8:24am

Vertex’s latest autoimmune TCE play involves $28M to AbCellera

Jul 29, 2026 8:20am

Jazz, AbCellera strike TCE discovery and development deal

Jun 17, 2026 7:00am

Takeda taps longtime Lilly exec as US head—Chutes & Ladders

Sep 12, 2025 8:30am

Photo of a paraglider passing tree-lined hills that are dark red from the leaves

MHRA CEO Raine to depart in Autumn —Chutes & Ladders

Mar 1, 2024 9:30am

Photo of an ax atop a pile of three logs

Prelude thinks SMARCA with AbCellera deal, culls 2 candidates

Nov 2, 2023 8:06am